Page last updated: 2024-11-10

org 24598

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

org 24598: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5311285
CHEMBL ID360052
SCHEMBL ID15127607
MeSH IDM0400098

Synonyms (18)

Synonym
bdbm50149856
{methyl-[(r)-3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amino}-acetic acid
org 24598
org-24598
CHEMBL360052 ,
2-[methyl-[(3r)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]amino]acetic acid
gtpl4600
SCHEMBL15127607
AKOS030210940
n-methyl-n-[(3r)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]-glycine
372198-97-5
kzwqawbtwnpfpw-qgzvfwflsa-n
Q27088213
n-methyl-n-[(3r)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]glycine
SDCCGSBI-0633675.P001
EX-A3499
(r)-2-(methyl(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)amino)acetic acid
AC-36401
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sodium- and chloride-dependent glycine transporter 1Homo sapiens (human)IC50 (µMol)0.22290.000412.2769106.0000AID1559417; AID241454
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
negative regulation of NMDA glutamate receptor activitySodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
neurotransmitter transportSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
glycine transportSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
positive regulation of hemoglobin biosynthetic processSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
regulation of synaptic transmission, glycinergicSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
positive regulation of heme biosynthetic processSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
transport across blood-brain barrierSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
glycine import across plasma membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
sodium ion transmembrane transportSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
synaptic transmission, glycinergicSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
glycine transmembrane transporter activitySodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
glycine:sodium symporter activitySodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
endosomeSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
plasma membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
basal plasma membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
postsynaptic densitySodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
basolateral plasma membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
apical plasma membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
lateral plasma membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
synaptic vesicle membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
dense core granuleSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
presynaptic membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
postsynaptic membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
parallel fiber to Purkinje cell synapseSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
plasma membraneSodium- and chloride-dependent glycine transporter 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1559417Inhibition of GlyT1B (unknown origin)2020Journal of medicinal chemistry, 04-23, Volume: 63, Issue:8
The Druggability of Solute Carriers.
AID241454Inhibition of uptake of [3H]-glycine into cells transfected with human GlyT-1b transporter2004Bioorganic & medicinal chemistry letters, Aug-02, Volume: 14, Issue:15
The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (53.33)29.6817
2010's4 (26.67)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.91

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.91 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.91)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]